Whitehawk Therapeutics (WHWK)

• Market cap: $184M
• 1 day: -0.26%
• 5 days: -4.41%
• 1 month: 32.65%
• 3 months: 62.5%
• 6 months: 100%
• Year to date: 59.84%
• 1 year: 85.71%
• 5 years: -84.05%
• 10 years: -93.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22